Trial · NCT03052127
Adverse events480
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 480
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anterior chamber cell | Eye disorders | Cohort 1 (Light-activated AU-011) | 1 | 3 | 1 |
| other | Anterior chamber cell | Eye disorders | Cohort 2 (Single Medium Dose Light-activated AU-011) | 1 | 3 | 1 |
| other | Anterior chamber cell | Eye disorders | Cohort 3 (Single High Dose Light-activated AU-011) | 1 | 3 | 2 |
| other | Anterior chamber cell | Eye disorders | Cohort 4 (2 Repeat Medium Dose Light-activated AU-011) | 0 | 3 | 0 |
| other | Anterior chamber cell | Eye disorders | Cohort 5 (3 Repeat Medium Dose Light-activated AU-011) | 0 | 3 | 0 |
| other | Anterior chamber cell | Eye disorders | Cohort 6 (Single High Dose Light-activated AU-011 x 2 Lasers) | 1 | 3 | 1 |
| other | Anterior chamber cell | Eye disorders | Cohort 7 (3 Repeat High Dose Light-activated AU-011) | 1 | 3 | 2 |
| other | Anterior chamber cell | Eye disorders | Cohort 8 (3 Repeat High Dose Light-activated AU-011 x 2 Lasers) | 0 | 3 | 0 |
| other | Anterior chamber cell | Eye disorders | Cohort 9 (Expansion 3 Repeat High Dose Light-activated AU-011 x 2 Lasers) | 3 | 12 | 5 |
| other | Anterior chamber cell | Eye disorders | Cohort 10 (Observation Until Documented Growth of Tumor) | 1 | 2 | 1 |
| other | Anterior chamber cell | Eye disorders | Cohort 11 (2 Cycles of 3 Repeat High Dose Light-activated AU-011x2 Lasers) | 2 | 5 | 3 |
| other | Anterior chamber cell | Eye disorders | Cohort 12 (2 Cycles 3 Repeat High Dose Light-activatedAU-011x2lasers) | 2 | 13 | 3 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 1 (Light-activated AU-011) | 1 | 3 | 1 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 2 (Single Medium Dose Light-activated AU-011) | 1 | 3 | 1 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 3 (Single High Dose Light-activated AU-011) | 0 | 3 | 0 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 4 (2 Repeat Medium Dose Light-activated AU-011) | 2 | 3 | 3 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 5 (3 Repeat Medium Dose Light-activated AU-011) | 3 | 3 | 3 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 6 (Single High Dose Light-activated AU-011 x 2 Lasers) | 1 | 3 | 1 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 7 (3 Repeat High Dose Light-activated AU-011) | 3 | 3 | 3 |
| other | Anterior chamber inflammation | Eye disorders | Cohort 8 (3 Repeat High Dose Light-activated AU-011 x 2 Lasers) | 2 | 3 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03052127/events